Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2011. Start Trial.
Date Value
July 31, 2026 77.82%
June 30, 2026 77.82%
May 31, 2026 77.82%
April 30, 2026 77.82%
March 31, 2026 77.82%
February 28, 2026 77.82%
January 31, 2026 77.82%
December 31, 2025 77.82%
November 30, 2025 77.82%
October 31, 2025 77.82%
September 30, 2025 77.82%
August 31, 2025 77.82%
July 31, 2025 77.82%
June 30, 2025 77.82%
May 31, 2025 77.82%
April 30, 2025 77.82%
March 31, 2025 77.82%
February 28, 2025 77.82%
January 31, 2025 77.82%
December 31, 2024 77.82%
November 30, 2024 77.82%
October 31, 2024 77.82%
September 30, 2024 77.82%
August 31, 2024 77.82%
July 31, 2024 77.82%
Date Value
June 30, 2024 77.82%
May 31, 2024 77.82%
April 30, 2024 77.82%
March 31, 2024 77.82%
February 29, 2024 75.87%
January 31, 2024 75.87%
December 31, 2023 75.87%
November 30, 2023 75.87%
October 31, 2023 75.87%
September 30, 2023 75.87%
August 31, 2023 75.87%
July 31, 2023 75.87%
June 30, 2023 75.87%
May 31, 2023 75.87%
April 30, 2023 75.87%
March 31, 2023 75.87%
February 28, 2023 75.87%
January 31, 2023 75.87%
December 31, 2022 75.87%
November 30, 2022 75.87%
October 31, 2022 75.87%
September 30, 2022 75.87%
August 31, 2022 68.73%
July 31, 2022 63.99%
June 30, 2022 58.59%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Autolus Therapeutics Plc 96.58%
argenx SE 38.20%
Evaxion AS 99.79%
Akari Therapeutics Plc 99.83%
Pharma Mar SA 98.44%